logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10435370 B1

PDFFull Text
Date of Patent:
Oct. 08, 2019

Filed:

Jul. 17, 2015

Quinoline derivatives for the treatment of inflammatory diseases

Applicants:

Abivax, Paris, FR;

Centre National DE LA Recherche Scientifique, Paris, FR;

Institut Curie, Paris, FR;

Universite DE Montpellier, Montpellier, FR;

Inventors:

Jamal Tazi, Clapiers, FR;

Romain Najman, L'Hay-les-Roses, FR;

Florence Mahuteau, Saint Remy les Chevreuses, FR;

Didier Scherrer, Castelnau le Lez, FR;

Karim Chebli, Frontingnan, FR;

Michael Hahne, Montpellier, FR;

Assignees:

ABIVAX, Paris, FR;

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, Paris, FR;

INSTITUT CURIE, Paris, FR;

UNIVERSITE DE MONTPELLIER, Montpellier, FR;

Attorney:

Oliff PLC

Primary Examiner:

D Margaret M Seaman

Int. Cl.
CPC ...
C07D 215/38 (2006.01); A61K 31/47 (2006.01); A61K 31/4709 (2006.01); A61K 31/497 (2006.01); A61K 31/5377 (2006.01); G01N 33/50 (2006.01); C12Q 1/6883 (2018.01); C07D 401/12 (2006.01);
U.S. Cl.
CPC ...
C07D 215/38 (2013.01); A61K 31/47 (2013.01); A61K 31/4709 (2013.01); A61K 31/497 (2013.01); A61K 31/5377 (2013.01); C07D 401/12 (2013.01); C12Q 1/6883 (2013.01); G01N 33/5023 (2013.01); G01N 33/5055 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/178 (2013.01);
Abstract

The present invention relates to a compound of formula (I) wherein: Formula (II) means an aromatic ring wherein V is C or N and when V is N; Q is N or O, provided that R″ does not exist when Q is O; R' independently represent a hydrogen atom or a group chosen among a (C-C)alkyl group, a halogen atom, a hydroxy! group, a —COORgroup, a —NO2 group, a —NRRgroup, a morpholinyl or a morpholino group, a N-methylpiperazinyl group, a (Ci-C3)fluoroalkyl group, a —O—P(═O)—(ORXOR) group, a (C-C)alkoxy group and a —CN group, and can further be a group chosen among: (IIa), (IIIa) or anyone of its pharmaceutically acceptable salt, for use in the treatment and/or prevention of an inflammatory disease.

Find Patent Forward Citations

Tazi, Jamal. (2019). Quinoline derivatives for the treatment of inflammatory diseases (U.S. Patent No. 10435370). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10435370

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…